0000908662-14-000299.txt : 20141202 0000908662-14-000299.hdr.sgml : 20141202 20141202132733 ACCESSION NUMBER: 0000908662-14-000299 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141202 DATE AS OF CHANGE: 20141202 EFFECTIVENESS DATE: 20141202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Intensity Therapeutics, Inc. CENTRAL INDEX KEY: 0001567264 IRS NUMBER: 461488089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-190523 FILM NUMBER: 141259971 BUSINESS ADDRESS: STREET 1: 40 RICHARDS AVENUE STREET 2: 3RD FLOOR CITY: NORWALK STATE: CT ZIP: 06854 BUSINESS PHONE: 914-329-6571 MAIL ADDRESS: STREET 1: 40 RICHARDS AVENUE STREET 2: 3RD FLOOR CITY: NORWALK STATE: CT ZIP: 06854 D/A 1 primary_doc.xml X0707 D/A LIVE 0001567264 Intensity Therapeutics, Inc. 8 Wright Street Suite 107 Westport CT CONNECTICUT 06880 203-682-2434 DELAWARE Intensity Therapeutics, LLC None Corporation true 2012 Lewis H. Bender 8 Wright Street, Suite 107 Westport CT CONNECTICUT 06880 Executive Officer Director Ian B. Walters, M.D. 8 Wright Street, Suite 107 Westport CT CONNECTICUT 06880 Executive Officer Robert Cooke 8 Wright Street, Suite 107 Westport CT CONNECTICUT 06880 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0000908662-14-000060 2013-01-05 true true true true true false 0 Cato Capital, LLC 133142 None None 31 Woodland Street, 11th Floor Hartford CT CONNECTICUT 06105 CA CALIFORNIA CT CONNECTICUT MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA TX TEXAS false Indefinite 1750000 Indefinite Offering of convertible notes, common stock, and warrants to purchase common stock (including underlying shares to be issued upon conversion of notes or exercise of warrants). false 20 40000 true 0 0 true false Intensity Therapeutics, Inc. /s/ Lewis H. Bender Lewis H. Bender President, Treasurer and Secretary 2014-11-24